BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 33155150)

  • 1. Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications.
    El Sabeh M; Afrin S; Singh B; Miyashita-Ishiwata M; Borahay M
    Stem Cell Rev Rep; 2021 Jun; 17(3):803-820. PubMed ID: 33155150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy.
    Verit FF; Yucel O
    Asian Pac J Cancer Prev; 2013; 14(10):5589-97. PubMed ID: 24289548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing adenomyosis: an integrated clinical and imaging approach.
    Chapron C; Vannuccini S; Santulli P; Abrão MS; Carmona F; Fraser IS; Gordts S; Guo SW; Just PA; Noël JC; Pistofidis G; Van den Bosch T; Petraglia F
    Hum Reprod Update; 2020 Apr; 26(3):392-411. PubMed ID: 32097456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma.
    Ono M; Bulun SE; Maruyama T
    Biol Reprod; 2014 Dec; 91(6):149. PubMed ID: 25376230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis.
    Benagiano G; Brosens I; Habiba M
    Hum Reprod Update; 2014; 20(3):386-402. PubMed ID: 24140719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-sponsored workshop: gynecology and women's health-benign conditions and cancer.
    Samimi G; Sathyamoorthy N; Tingen CM; Mazloomdoost D; Conroy J; Heckman-Stoddard B; Halvorson LM
    Am J Obstet Gynecol; 2020 Dec; 223(6):796-808. PubMed ID: 32835714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Junctional zone endometrium alterations in gynecological and obstetrical disorders and impact on diagnosis, prognosis and treatment.
    Tanos V; Balami S; Lingwood L
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):418-427. PubMed ID: 31573995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innervation of endometrium and myometrium in women with painful adenomyosis and uterine fibroids.
    Zhang X; Lu B; Huang X; Xu H; Zhou C; Lin J
    Fertil Steril; 2010 Jul; 94(2):730-7. PubMed ID: 19368910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elastin distribution in the normal uterus, uterine leiomyomas, adenomyosis and adenomyomas: a comparison.
    Zheng WQ; Ma R; Zheng JM; Gong ZJ
    Anal Quant Cytol Histol; 2006 Apr; 28(2):115-20. PubMed ID: 16637515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of somatic stem cells in leiomyoma formation.
    Mas A; Cervello I; Gil-Sanchis C; Simón C
    Fertil Steril; 2014 Sep; 102(3):613-20. PubMed ID: 24890270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment.
    Yen CF; Huang SJ; Lee CL; Wang HS; Liao SK
    Reprod Sci; 2017 Oct; 24(10):1346-1361. PubMed ID: 28183227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. There is no significant correlation of adenomyosis with benign, premalignant and malignant gynecological pathologies. Retrospective study on 647 specimens.
    Matalliotakis M; Zervou MI; Matalliotaki C; Goulielmos GN; Krithinakis K; Kapetanios G; Kalogiannidis I
    Ginekol Pol; 2022; 93(6):467-472. PubMed ID: 35072225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological changes associated with adenomyosis: a systematic review.
    Bourdon M; Santulli P; Jeljeli M; Vannuccini S; Marcellin L; Doridot L; Petraglia F; Batteux F; Chapron C
    Hum Reprod Update; 2021 Jan; 27(1):108-129. PubMed ID: 33099635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
    Szubert M; Kozirog E; Wilczynski J
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine stem cells: from basic research to advanced cell therapies.
    Santamaria X; Mas A; Cervelló I; Taylor H; Simon C
    Hum Reprod Update; 2018 Nov; 24(6):673-693. PubMed ID: 30239705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and Pathogenesis of Adenomyosis.
    Antero MF; Ayhan A; Segars J; Shih IM
    Semin Reprod Med; 2020 May; 38(2-03):108-118. PubMed ID: 33080632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective myometrial spiral artery remodelling as a cause of major obstetrical syndromes in endometriosis and adenomyosis.
    Brosens I; Pijnenborg R; Benagiano G
    Placenta; 2013 Feb; 34(2):100-5. PubMed ID: 23232321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles.
    Bourdon M; Oliveira J; Marcellin L; Santulli P; Bordonne C; Maitrot Mantelet L; Millischer AE; Plu Bureau G; Chapron C
    Hum Reprod; 2021 Jan; 36(2):349-357. PubMed ID: 33491057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.